RYTM - Rhythm Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$140.20
DETAILS
HIGH:
$157.00
LOW:
$125.00
MEDIAN:
$143.00
CONSENSUS:
$140.20
UPSIDE:
59.61%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 89.7% |
| EBIT Margin | -92.5% |
| EBITDA Margin | -91.8% |
| Operating Margin | -101.2% |
| Pretax Margin | -103.3% |
| Cont. Ops Margin | -103.6% |
| Net Margin | -103.6% |
| Bottom Line Margin | -106.4% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 4.41 |
| Quick Ratio | 4.16 |
| Solvency Ratio | -0.571 |
| Cash Ratio | 0.51 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-35.39
Peers avg: 25.2
|
| PEG Ratio | 1.25 |
| Forward PEG | 1.25 |
| Price/Book | 50.02 |
| Price/Sales | 36.66 |
| Price/FCF | -59.64 |
| Price/Op Cash Flow | -60.13 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.5122 |
| Debt/Equity | 1.7723 |
| Debt/Capital | 0.6393 |
| Long-Term Debt/Capital | 0.6284 |
| Financial Leverage | 3.46 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.61 |
| Operating Cash Flow Ratio | -1.092 |
| Operating Cash Flow/Sales | -61.0% |
| Free Cash Flow/Operating Cash Flow | 100.8% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -6.12 |
| Interest Coverage | -9.3289 |
| Short-Term Operating Cash Flow Coverage | -14.56 |
| Operating Cash Flow Coverage | -0.47 |
| Capital Expenditure Coverage | -121.38 |
| Dividend + Capital Expenditure Coverage | -121.38 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 2.92 |
| EPS | -3.024 |
| Debt/Share | 4.1095 |
| Cash/Share | 5.99 |
| Book Value/Share | 2.14 |
| Tangible BV/Share | 2.06 |
| Equity/Share | 2.14 |
| Operating Cash Flow/Share | -1.780 |
| Capital Expenditure/Share | 0.015 |
| FCF/Share | -1.795 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.003 |
| Earnings Before Tax/EBIT | 1.021 |
| Price/Fair Value | 50.02 |
| Debt/Market Cap | 0.0350 |
| Effective Tax Rate | -0.3% |
| Enterprise Value Multiple | -41.05 |